1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. QIAGEN NV
Qiagen NV
XNYS: QGEN
Turnaround Potential
Download real time
45.380.85(1.91%)
39.50% Gain from 52W Low
1.3M
XNYS Volume

XNYS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Qiagen NV quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Qiagen NV share price target, revenues, EPS, net income and more

Qiagen NV quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Qiagen NV Jun-2026 Quarterly Revenue is $535 Million which is growth of 0.3% YoY.

  • POSITIVE

    Quarterly Net Profit Qiagen NV Jun-2026 Quarterly Net Profit is $103 Million which is growth of 7.4% YoY.

Qiagen NV, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
535492.3540.4532.6533.5483.5521.2501.9496.4458.8509.2475.9494.9
Cost Of Rev.
194.7182.7215.2201.3199.3174.8187.9193.6461.6167.8193.1177.9182.7
Gross Profit
340.4309.6325.3331.3334.3308.7333.3308.334.8291316.1298312.2
⌄
199.5193203.4194198.3183.5192.1187.5195.1192.7194.6190.8198.1
Operating Profit
140.9116.6121.9137.3136125.2141.2120.9-160.498.2121.5107.2114
⌄
-0.7-0.59.96.96.38.146.867.56.87.47.9
Profit Before Tax
132.185.8109.2134.7126.8119.6125.9116.5-223.5102.3118.999.8102.3
Tax
28.717.81.34.730.628.837.518.4-4021.621.22221.5
⌄
103.468107.813096.390.888.398.1-183.580.797.777.880.8
Diluted NI Avail to Com Stockholders Ann.
103.468107.813096.390.888.398.1-183.580.797.777.880.8
Basic EPS
0.50.30.50.60.50.40.40.5-0.90.40.50.40.4
Diluted EPS After ExtraOrdinary
0.50.50.60.70.50.50.50.5-0.60.40.50.40.4
Number Of Shares End
206.4207206.1206205.9207.5205.4205.3205204.9204.5204.5204.4
Net Income Continuing Discontinued Operations
103.468107.813096.390.888.398.1-183.580.797.777.880.8
Normalized Income
115.10.1166133.5115.1135.6136.4128122.7103.6127.2115.20.1
Interest Income
9.410.62015.113.915.415.118.316.917.819.320.421.3
Interest
1011.110.18.27.67.311.111.510.910.312.41313.5
Net Interest Income
-0.7-0.59.96.96.38.146.867.56.87.47.9
EBIT
132.886.399.3127.9120.6111.5121.9109.7-229.494.8112.192.594.5
EBITDA
183.3137.5148.7178.8170155.4167.5159.7-176.1149.2163.6143145.6
Reconciled Cost Of Rev.
146.4133.8168152.5151.6132.7144.2145.9410.9116.2144.2130.1134.3
Reconciled Depr.
50.651.249.45149.543.945.65053.454.351.650.651.1
Profit From Continuing Operations
103.468107.813096.390.888.398.1-183.580.797.777.880.8
Normalized EBITDA
201.9180.3191.1202200.6184.4204.6186.7-91.1170.2193.8173.4175.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Qiagen NV competitor comparison and performance snapshot within industry

Qiagen NV annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Qiagen NV Dec-2025 Annual Revenue is $2,090 Million which is growth of 5.7% YoY.

  • POSITIVE

    Annual Net Profit Qiagen NV Dec-2025 Annual Net Profit is $425 Million which is growth of 408.3% YoY.

Qiagen NV, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-0.8%
2.2%
 2,0901,978.21,965.32,141.52,251.71,870.41,526.41,501.91,417.51,3381,281
Cost Of Rev. Ann.
1.5%
4.4%
793.8790.51,010.9731.6757800.8637.6521.2500.9495493.3454.6
Gross Profit Ann.
-2.1%
1.1%
1,306.51,299.5967.41,233.71,384.61,450.81,232.71,005.31,001922.6844.7826.4
Operating Exp. Ann.
-1.2%
2.3%
789.9779.2767.5788.4808.3793695.2691.6734.4769.1745.8650.7
Operating Profit Ann.
-3.3%
-0.6%
516.6520.3199.9445.3576.2657.9537.5313.7266.6153.498.8175.7
⌄
-
-
15.631.124.225.6-25.6-44.9-61.3-52.1-46.4-39-32.3-32.6
Other Exp. Ann.
-
-
 -61.1-102.9-41-3812.9-36.7-339.45.6-9.7-10.6
PBT Ann.
-1.5%
2.2%
461.8490.3121.2429.8512.6625.8439.5-77.8225.7114.456.9132.5
Tax Ann.
-9.9%
-4%
52.565.437.688.589.4113.280.3-36.335.474-23.45.6
⌄
0.1%
3.4%
409.3424.983.6341.3423.2512.6359.2-41.5190.440.480.4127.1
Diluted NI Avail to Com Stockholders Ann.
0.1%
3.4%
409.3424.983.6341.3423.2512.6359.2-41.5190.440.480.4127.1
EPS Ann.
0%
3.1%
 2.10.41.72.12.51.8-0.20.90.20.40.6
Diluted EPS Ann.
-1.6%
3.3%
 20.41.72.12.51.7-0.20.90.20.40.6
Number Of Shares End
0.3%
0.1%
 206.1205.4204.5204.1203.5204.8204.1202.2203202.9201.6
Total Exp. Ann.
0.1%
3.3%
 1,569.71,778.31,520.11,565.31,593.81,332.91,212.81,235.31,264.11,239.21,105.3
Net Income Continuing Discontinued Operations Ann.
0.1%
3.4%
409.3424.983.6341.3423.2512.6359.2-41.5190.440.480.4127.1
Normalized Income Ann.
1.2%
5.2%
414.7536.1490.8476.9516.9542.6415.2268.6311.970.9133.8171.5
Interest Income Ann.
25.2%
45.1%
5564.3687932.89.61022.120.910.66.84.8
Interest Ann.
-17.1%
-14.1%
39.433.343.853.458.454.571.374.267.349.73937.4
EBITDA Ann.
-4.4%
-1.5%
648.4653300.2609.6746.6885.7705.8205.8478.6369.9302.2356.6
Reconciled Cost Of Rev. Ann.
2.4%
5.9%
600.8604.8817.2537.1563.1604.5453.4319.7333.5317.9319.4301.8
Reconciled Depr. Ann.
-2.4%
-1.1%
202.1193.8203.3205.3208.4214.9205231.5206.4216.5213.1191.5
Profit From Continuing Operations Ann.
0.1%
3.4%
409.3424.983.6341.3423.2512.6359.2-41.5190.440.480.3126.9
Normalized EBITDA Ann.
-2.2%
-2.3%
775.4771.7470.4723.9824.1923866.8567.7499.5380.5309361.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
5.7%
2Y CAGR
3.1%
3Y CAGR
-0.8%
5Y CAGR
2.2%
7Y CAGR
4.8%
10Y CAGR
5%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
408.3%
2Y CAGR
11.6%
3Y CAGR
0.1%
5Y CAGR
3.4%
7Y CAGR
12.2%
10Y CAGR
12.8%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
1.5%
2Y CAGR
-0.6%
3Y CAGR
-1.2%
5Y CAGR
2.3%
7Y CAGR
0.8%
10Y CAGR
1.8%
Operating Expenses Annual Cr growth is stable compared to historical averages.

Qiagen NV balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Qiagen NV Dec-2025 Total Shareholders Fund is $3,778 Million which is growth of 5.9% YoY.

  • POSITIVE

    Total Assets Qiagen NV Dec-2025 Total Assets is $6,281 Million which is growth of 10.4% YoY.

Qiagen NV, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
0%
1.2%
6,281.25,689.66,115.26,287.76,1475,912.55,235.65,748.35,038.54,308.24,189.7
⌄
-3.9%
-4.3%
2,503.12,122.32,307.42,821.13,050.43,114.72,6993,113.42,497.51,701.11,627.7
⌄
2.9%
6.2%
3,778.23,567.33,807.83,466.63,096.62,797.82,536.62,6352,5412,607.12,559.9
Total Capitalization Ann.
3.2%
3%
5,432.64,905.44,729.64,938.54,190.74,678.13,957.74,306.14,299.33,674.23,619.5
Tangible Assets Ann.
6.7%
-
691.1838.1805.2569.3118.4-292.4-236.451.428.8124.447.8
Working Capital Ann.
1.5%
7.1%
1,482.91,416.21,068.31,419.4592.11,052.2618.91,182.91,323.2729.1693.3
Invested Capital Ann.
0.6%
2.8%
5,432.64,958.95,317.65,328.15,038.34,720.64,242.94,809.24,299.33,674.23,619.5
Tangible Book Value Ann.
6.7%
-
691.1838.1805.2569.3118.4-292.4-236.451.428.8124.447.8
Borrowings Ann.
-1.3%
-1.4%
1,812.41,415.91,532.11,883.71,963.81,946.21,725.12,174.31,759.61,068.11,060.5
Net Debt Ann.
-10.3%
-9.3%
815.4728841.71,130.81,061.31,324.81,082.71,015.11,100.5627.9769.6
Share Issued Ann.
0%
0%
206.8206.8206.8206.8206.8206.8206.8206.8206.8206.8206.8
Number Of Shares End
0.3%
0.1%
206.1205.4204.5204.1203.5204.8204.1202.2203202.9201.6
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
10.4%
2Y CAGR
1.3%
3Y CAGR
0%
5Y CAGR
1.2%
7Y CAGR
1.3%
10Y CAGR
4.1%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-5.8%
2Y CAGR
-31.1%
3Y CAGR
-19.3%
5Y CAGR
-3.6%
7Y CAGR
-8.8%
10Y CAGR
6.7%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
5.9%
2Y CAGR
-0.4%
3Y CAGR
2.9%
5Y CAGR
6.2%
7Y CAGR
5.3%
10Y CAGR
4%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

Qiagen NV ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share Qiagen NV Book Value Per Share is $18 which is growth of 5.5% YoY.

  • NEUTRAL

    ROE Qiagen NV ROE is 0% which is growth of 0% YoY.

Qiagen NV, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-1.42%5.50%6.81%8.50%6.44%-0.75%3.53%0.86%1.89%2.94%
ROE Ann. %
-
-
-2.27%9.38%12.90%17.39%13.47%-1.60%7.36%1.57%3.11%4.88%
ROIC %
-
-
-1.61.81.62.74.91.31.6-0.80.41.5
OPM Ann. %
-2.6%
-2.8%
24.90%10.11%22.66%26.91%29.22%28.74%20.55%17.75%10.82%7.39%13.72%
Inventory Turnover Ratio Ann.
-
-
-31.92.22.62.83.13.13.43.63.4
Asset Turnover Ann. %
-
-
-0.30.30.30.40.30.30.30.30.30.3
Working Capital Turnover Ann.
-2.3%
-4.9%
1.41.41.81.53.81.82.51.31.11.81.9
Quick Ratio Ann.
-
-
-31.51.9121.31.94.42.82.8
Current Ratio Ann.
-
-
-3.622.51.42.71.72.25.13.43.6
Interest Coverage Ratio Ann.
-
-
-3.89.19.812.57.2-0.14.43.32.54.5
LT Debt To Equity Ann.
-
-
-0.40.20.40.40.70.60.60.70.40.4
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Qiagen NV cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Qiagen NV Dec-2025 Cash From Operating Activity is $654 Million which is growth of -2.9% YoY.

  • POSITIVE

    Net Cash Flow Qiagen NV Dec-2025 Net Cash Flow is $170 Million which is growth of 11826.4% YoY.

Qiagen NV, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-2.9%
7.4%
654.3673.6459.5715.3639457.8330.8359.5286.8341.6317.5
⌄
-
-
-305.3-249.2-87.7-726.8-202.4-443.3-222.3-211.4-464.3-179.1-146.2
⌄
-
-
-179-422.9-433.8-125.8-150.4-50.1-639.1360.4387.2-10.6-258.6
Cash Plus Cash Eqv. End Of Year Ann.
4.7%
7%
839663.6668.1730.7880.5598629.41,159.1657.7439.2290
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
170.11.4-62-137.3286.2-35.6-530.5508.6209.7151.9-87.3
Cash Plus Cash Eqv. Begin Of Year Ann.
-9%
1.1%
663.6668.1730.7880.5598629.41,159.1657.7439.2290392.7
Income Tax Paid Supplemental Data Ann.
-44%
-16.5%
17.315.782.498.6102.142.641.529.340.522.734.4
Interest Paid Supplemental Data Ann.
8.1%
2.9%
29.324.220.423.221.625.429.725.920.318.220.8
Capex Ann.
-
-
-207.1-171.2-162.8-149.3-206.5-304.2-274.9-150.8-124.4-93.9-117.5
Issuance Of Capital Stock Ann.
-
-
--0.20.17.97.72.14.46.16.310.3
Issuance Of Debt Ann.
26%
5.9%
742.3494.2371.5557494.9724.3--
Repayment Of Debt Ann.
-
-
-534.2-601.5-436.8-480-41.3-592.5-640.2-1.3-1.4-8.1-253
Repurchase Of Capital Stock Ann.
-
-
--292.1-100-64-74.5-104.7-61-20.8
Free Cash Flow Ann.
-7.5%
23.8%
447.2502.3296.7565.9432.5153.656208.7162.4247.7200
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-2.9%
2Y CAGR
19.3%
3Y CAGR
-2.9%
5Y CAGR
7.4%
7Y CAGR
8.9%
10Y CAGR
7.5%
Cash from Operating Activity Annual is falling faster than historical averages.
×